A5033030552- CAR-T cell therapy research
- SARS-CoV-2 and COVID-19 Research
- Dialysis and Renal Disease Management
- Chronic Lymphocytic Leukemia Research
- Cancer Immunotherapy and Biomarkers
- Mosquito-borne diseases and control
- Virus-based gene therapy research
- Immune responses and vaccinations
- Viral Infections and Immunology Research
- Cystic Fibrosis Research Advances
- Long-Term Effects of COVID-19
- RNA Interference and Gene Delivery
- Infectious Encephalopathies and Encephalitis
- Pancreatitis Pathology and Treatment
- Central Venous Catheters and Hemodialysis
- Stroke Rehabilitation and Recovery
- Stress Responses and Cortisol
- Immunotherapy and Immune Responses
- COVID-19 Clinical Research Studies
- Effects and risks of endocrine disrupting chemicals
- Pancreatic and Hepatic Oncology Research
- Inflammatory mediators and NSAID effects
- Synthesis and Biological Evaluation
- Multiple Myeloma Research and Treatments
- Immunodeficiency and Autoimmune Disorders
Binghamton University
2012-2023
Tel Aviv Sourasky Medical Center
2021
Tel Aviv University
2021
Center for Research and Advanced Studies of the National Polytechnic Institute
2010
Instituto Politécnico Nacional
2010
Hospital General de México
2005
Data are scarce regarding both the safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains receiving this after allogeneic hematopoietic transplantation (HCT; n = 66) or CD19-based chimeric antigen receptor T (CART) therapy (n 14). Overall, was well tolerated, with mild non-hematologic vaccine-reported adverse events a minority patients. Twelve percent first dose 10% second developed cytopenia,...
Summary Multiple myeloma (MM) patients are at excess risk for clinically significant COVID19 infection. BNT162b2 mRNA (BNT162b2) vaccine provides effective protection against the general population, yet its effect in MM may be compromised due to disease and therapy‐related factors was not evaluated. This single‐centre prospective study included tested serological response 14–21 days post second vaccine. Vaccinated healthy volunteers served as controls. In all, 171 patients, median age 70...
BACKGROUNDStudies on experimental animals have found that organophosphate (OP) pesticides may act as endocrine disruptors; however, their effects the human hormonal profile not yet been adequately characterized. We evaluate association between exposure to OP pesticides, measured through dialkyl phosphate (DAP) metabolites urinary levels, and male hormone profile.
We conducted a randomized, crossover study in 23 healthy young female volunteers to compare the bioavailability of two brands meloxicam (7.5 mg) tablets and obtain pharmacokinetic parameters this molecule Mexican population not reported previously. Two (15 were administered as single dose on 2 treatment days separated by 1-week washout period. After dosing, serial blood samples collected for period 72 h. Plasma harvested was analyzed modified validated high-performance liquid chromatography...
Automated peritoneal dialysis (APD) employs cyclers to control inflow and outflow of the fluid patient's abdomen. To allow more patients use this modality, should support achievement an adequate dose be easy use, cost-effective, silent. The new SILENCIA cycler (Fresenius Medical Care, Bad Homburg, Germany), designed improve these characteristics in comparison its predecessor device, was evaluated respect a prospective study.This cross-over study comprised two 2-week periods, separated by...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)